Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
2.780
-0.200 (-6.71%)
At close: Jun 27, 2025, 4:00 PM
2.920
+0.140 (5.04%)
After-hours: Jun 27, 2025, 7:10 PM EDT

Orchestra BioMed Holdings Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
107152326112206262
Market Cap Growth
-13.03%-53.41%191.65%-45.72%-21.31%-
Enterprise Value
7387229193--
Last Close Price
2.994.009.139.9810.0812.81
PS Ratio
38.7857.64118.2431.67-263.6045.94
PB Ratio
6.804.614.802.13-10.4290.02
P/TBV Ratio
6.324.614.802.13--
EV/Sales Ratio
25.3232.9782.9654.51--
Debt / Equity Ratio
0.980.500.030.23-0.293.25
Asset Turnover
0.040.030.030.07--
Inventory Turnover
1.711.280.881.232.91-
Quick Ratio
3.234.137.824.520.902.50
Current Ratio
3.354.277.954.560.932.52
Return on Equity (ROE)
-179.12%-120.84%-81.47%-205.22%--
Return on Assets (ROA)
-60.70%-46.90%-33.75%-37.42%-52.79%-
Return on Capital (ROIC)
-93.36%-67.42%-48.00%-81.16%--
Earnings Yield
-62.26%-40.13%-15.05%-30.04%-11.16%-8.15%
FCF Yield
-51.13%-33.44%-14.16%-26.70%-9.56%-10.20%
Buyback Yield / Dilution
-6.17%-10.82%-121.67%-609.97%-4.86%-
Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q